Clariant AG (CLZNY) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $4.17B is the value of all shares combined. Beta 0.42: the stock has moved about 58% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerClariant AG (CLZNY) trades at $12.68. Clariant AG is a Swiss multinational specialty chemical company operating through Care Chemicals, Catalysis, and Natural Resources segments. Market cap: $4.17B, Sector: Basic materials.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for CLZNY: CLZNY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CLZNY against Basic Materials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
CLZNY: 1/2 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Clariant AG (CLZNY) Materials & Commodity Exposure
Clariant AG, a Swiss-based specialty chemical company, delivers tailored solutions across diverse sectors, including personal care, agriculture, and energy. With a focus on innovation and sustainability, Clariant competes in the global specialty chemicals market, offering products like catalysts, additives, and functional minerals.
What Is the Investment Thesis for CLZNY?
Clariant AG presents a mixed investment thesis. The company's diverse portfolio of specialty chemicals offers exposure to various end markets, potentially mitigating cyclical risks. The dividend yield of 5.74% may attract income-seeking investors. However, the negative P/E ratio of -31.87 and a negative profit margin of -1.9% raise concerns about profitability. Future growth will depend on the successful execution of its strategic initiatives and the ability to navigate competitive pressures. Investors should closely monitor the company's financial performance and industry trends.
Based on FMP financials and quantitative analysis
CLZNY Key Highlights
Market capitalization of $4.17B reflects its position in the specialty chemicals market.
- Dividend yield of 5.74% may appeal to income-focused investors.
- Negative P/E ratio of -31.87 indicates current earnings challenges.
- Gross margin of 31.2% shows the profitability of its products before operating expenses.
- Beta of 0.42 suggests lower volatility compared to the overall market.
Who Are CLZNY's Competitors?
CLZNY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AZLGF Azelis Group N.V. | $14.12 | 0.00% | $3.44B | — |
| DACHF Daicel Corporation | $9.38 | 0.00% | $2.40B | — |
| HXPLF HEXPOL AB (publ) | $9.66 | 0.00% | $3.18B | 449-signal |
| KPTCY Kansai Paint Co., Ltd. | $8.02 | 0.00% | $2.82B | — |
| CBT Cabot Corporation | $78.84 | +0.06% | $4.07B | 675-pillar |
| AVNT Avient Corporation | $41.72 | -0.43% | $3.83B | 575-pillar |
| FUPEF Fuchs Petrolub SE | $37.00 | 0.00% | $4.85B | 499-signal |
| BCPC Balchem Corporation | $166.67 | -0.99% | $5.36B | 835-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are CLZNY's Key Strengths?
Diverse product portfolio
- Global presence
- Technological expertise
- Strong customer relationships
What Are CLZNY's Weaknesses?
Negative profitability
- High debt levels
- Exposure to cyclical industries
- Complexity of operations
What Could Drive CLZNY Stock Higher?
Focus on sustainable and eco-friendly chemical solutions could attract environmentally conscious investors and customers.
- Expansion into emerging markets, particularly in Asia-Pacific and Latin America, could drive revenue growth.
- Development and launch of new, advanced catalysts for various chemical processes could improve efficiency and reduce costs for customers.
- Innovation in personal care ingredients to meet the increasing demand for natural and sustainable products.
- Digitalization of chemical management through the Veritrax system could improve customer efficiency and generate new revenue streams.
What Are the Key Risks for CLZNY?
Negative return on equity (-3.8%) — the business is not currently generating profit on shareholder capital.
- Economic downturn could reduce demand for specialty chemicals across various industries.
- Increased competition from other chemical companies could erode market share and pricing power.
- Fluctuations in raw material prices could negatively impact profitability.
- Regulatory changes related to environmental protection and chemical safety could increase compliance costs.
- Negative P/E ratio and profit margin indicate financial challenges that could affect investor confidence.
What Are the Growth Opportunities for CLZNY?
- Growth opportunity 1: Expansion in sustainable chemicals: Clariant can capitalize on the increasing demand for eco-friendly and sustainable chemical solutions. By investing in research and development of bio-based and recyclable materials, Clariant can attract environmentally conscious customers and gain a competitive edge. The global market for green chemicals is projected to reach $100 billion by 2028, offering substantial growth potential.
- Growth opportunity 2: Penetration of emerging markets: Emerging markets, such as Asia-Pacific and Latin America, offer significant growth opportunities for Clariant. These regions are experiencing rapid industrialization and urbanization, driving demand for specialty chemicals in various applications. By establishing a stronger presence in these markets, Clariant can tap into new revenue streams and diversify its geographic footprint. The emerging markets chemicals sector is expected to grow at a CAGR of 6% over the next five years.
- Growth opportunity 3: Development of advanced catalysts: Clariant's Catalysis segment can drive growth by developing advanced catalysts for various chemical processes. These catalysts can improve efficiency, reduce waste, and lower production costs for customers in the petrochemical, refining, and chemical industries. The global catalysts market is projected to reach $40 billion by 2027, presenting a significant opportunity for Clariant.
- Growth opportunity 4: Innovation in personal care ingredients: The Care Chemicals segment can expand its market share by developing innovative and high-performance ingredients for personal care products. Consumers are increasingly seeking products with natural, sustainable, and effective ingredients. By focusing on research and development in this area, Clariant can capture a larger share of the growing personal care market.
- Growth opportunity 5: Digitalization of chemical management: Clariant's Veritrax system offers an intelligent chemical management solution for the oil and gas industry. By expanding the capabilities of this system and offering it to other industries, Clariant can generate new revenue streams and improve customer efficiency. The market for digital solutions in the chemical industry is growing rapidly, driven by the need for improved data analytics and process optimization.
What Are CLZNY's Competitive Advantages?
- Specialized Product Portfolio: Clariant's focus on specialty chemicals provides a degree of differentiation and pricing power.
- Technological Expertise: The company's investment in R&D and innovation creates a competitive advantage.
- Established Customer Relationships: Long-standing relationships with key customers provide a stable revenue base.
- Global Presence: Clariant's global footprint allows it to serve customers in diverse markets.
What Does CLZNY Do?
Founded in 1886 and headquartered in Muttenz, Switzerland, Clariant AG has evolved into a global leader in the specialty chemicals industry. The company operates through three primary segments: Care Chemicals, Catalysis, and Natural Resources. Clariant's Care Chemicals segment provides ingredients and solutions for personal care, home care, and industrial applications. The Catalysis segment develops and produces catalysts for various chemical processes, including petrochemical refining and synthesis gas production. The Natural Resources segment offers bentonite-based specialty products and chemical solutions for the oil, gas, and mining industries. Clariant serves a wide range of industries, including automotive, construction, agriculture, healthcare, and consumer goods. The company's products include flame retardants, performance additives, advanced surface solutions, and various specialty chemicals. Clariant's geographic reach spans across the globe, with manufacturing facilities and sales offices in numerous countries. Clariant competes with other major players in the specialty chemicals market, focusing on innovation, sustainability, and customer-specific solutions.
What Products and Services Does CLZNY Offer?
- Develops and produces specialty chemicals.
- Offers solutions for the care chemicals market, including ingredients for personal and home care products.
- Creates catalysts for petrochemical refining and chemical processes.
- Provides bentonite-based specialty products for oil purification and other industrial applications.
- Offers chemical solutions for the oil, gas, and mining industries.
- Develops and markets pigments, dyes, and specialty materials for various applications.
- Provides flame retardants, performance additives, and advanced surface solutions.
How Does CLZNY Make Money?
- Clariant generates revenue by selling specialty chemicals and solutions to various industries.
- The company operates through three segments: Care Chemicals, Catalysis, and Natural Resources.
- Clariant focuses on innovation and customer-specific solutions to differentiate itself from competitors.
- The company invests in research and development to create new products and improve existing ones.
What Industry Does CLZNY Operate In?
Clariant AG operates within the specialty chemicals industry, a sector characterized by innovation, customization, and high-performance products. The industry caters to diverse end markets, including personal care, agriculture, automotive, and construction. Market trends include a growing demand for sustainable and eco-friendly solutions, as well as increasing regulatory scrutiny. Clariant competes with other major players in the industry, such as AZLGF (Asahi Kasei), DACHF (BASF), HXPLF (LANXESS), KPTCY (Kao Corporation), and KSANF (Shin-Etsu Chemical), each vying for market share through product differentiation and customer service.
Who Are CLZNY's Key Customers?
- Personal care product manufacturers
- Home care product manufacturers
- Petrochemical companies
- Refineries
- Oil and gas companies
- Mining companies
- Manufacturers of coatings, plastics, and inks
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
- ● Reported in CHF, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 41 |
| 2026-08-26 | 41 |
| 2026-08-29 | 41 |
| 2026-09-01 | 41 |
| 2026-09-04 | 41 |
| 2026-09-07 | 41 |
| 2026-09-10 | 41 |
What changed?
The score has stayed at 41.
Over the same 18 days the stock moved -4.2%.
Earnings Track Record
Clariant AG has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 17.8% below estimates on average.
Financial Health
Clariant AG's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.07 places it in the safe zone, indicating low near-term bankruptcy risk.
Key Financial Metrics
Return on equity for Clariant AG stands at -3.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -1.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 10.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.64 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -3.3%, the inverse of the P/E and a quick read on earnings relative to price.
Clariant AG (CLZNY) Valuation Context
Valued at $4.17B, CLZNY is classified as a mid-cap stock.
CLZNY Revenue & Earnings Trend
In Q2 FY2026, CLZNY generated $2.33B in top-line revenue, marking a sequential decrease of 1.0%. The company recorded net income of $88.0M, with diluted EPS of $0.27. Revenue has contracted over three consecutive quarters, which investors in this mid-cap Basic Materials stock should monitor closely. Across the four most recent quarters, CLZNY averaged $0.08 in diluted EPS.
Company Profile
Clariant AG operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Muttenz, CH. The company is led by CEO Conrad Keijzer. CLZNY has traded publicly since 2009.
CLZNY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diverse product portfolio
- Global presence
- Technological expertise
- Strong customer relationships
Bear Case
- Negative profitability
- High debt levels
- Exposure to cyclical industries
- Complexity of operations
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $2.33B | $88M | $0.27 |
| Q4 FY2025 | $2.35B | -$123M | -$0.38 |
| Q2 FY2025 | $2.43B | $32M | $0.10 |
| Q4 FY2024 | $2.55B | $107M | $0.32 |
Q2 FY2026 · filed 30 Jun 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis · Converted to USD from CHF at today's rate
CLZNY Latest News
-
Clariant AG (OTCMKTS:CLZNY) Receives Average Recommendation of “Hold” from Analysts
defenseworld.net · Aug 17, 2026
-
Clariant AG (CLZNY) (Q2 2026) Earnings Call Highlights: Legal Victory and Strategic Resilience ...
GuruFocus.com · Jul 31, 2026
-
Clariant AG (CLZNY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 31, 2026
-
Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021
· Jul 23, 2021
CLZNY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CLZNY.
Price Targets
Wall Street price target analysis for CLZNY.
CLZNY MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CLZNY; grades run from A+ (80-100) to F (below 30).
Latest News
Clariant AG (OTCMKTS:CLZNY) Receives Average Recommendation of “Hold” from Analysts
Clariant AG (CLZNY) (Q2 2026) Earnings Call Highlights: Legal Victory and Strategic Resilience ...
Clariant AG (CLZNY) Q2 2026 Earnings Call Transcript
Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021
Leadership: Conrad Keijzer
CEO
Conrad Keijzer is the CEO of Clariant AG. He has a strong background in the chemical industry, with extensive experience in various leadership roles. Prior to joining Clariant, he held senior positions at Royal DSM, a global science-based company active in health, nutrition, and materials. His experience includes leading business transformations, driving innovation, and expanding into new markets. He has a proven track record of delivering results and creating value for shareholders.
Track Record: Since becoming CEO, Conrad Keijzer has focused on streamlining Clariant's operations, improving profitability, and strengthening its position in key markets. He has overseen the divestment of non-core businesses and the implementation of cost-saving measures. Under his leadership, Clariant has also made strategic investments in sustainable chemicals and digital solutions.
Clariant AG ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. CLZNY is an ADR representing shares of Clariant AG, a Swiss company. This allows U.S. investors to invest in Clariant without directly dealing with foreign exchanges.
- Home Market Ticker: SIX Swiss Exchange, Switzerland
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: CLZN
CLZNY OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market. Companies in this tier may have limited financial disclosure, and there may be less information available to investors compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for fraud, manipulation, and lack of liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure
- Low liquidity
- Potential for fraud or manipulation
- Lack of regulatory oversight
- Difficulty in obtaining accurate information
- Verify the company's registration and legal status.
- Obtain and review the company's financial statements, if available.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before investing.
- Check for any news or regulatory actions related to the company.
- Established operating history
- Presence of a reputable management team
- Availability of some financial information
- Positive news coverage or industry recognition
- Listing on a foreign exchange
Common Questions About CLZNY (Basic Materials)
Is CLZNY a good stock?
Stock Expert AI does not rate CLZNY buy, sell or hold. Clariant AG has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
How does Clariant AG compare to competitors in its industry?
Clariant AG competes with major players like BASF (DACHF), Asahi Kasei (AZLGF), and LANXESS (HXPLF) in the specialty chemicals market. Clariant distinguishes itself through its focus on specific niches and tailored solutions. While BASF has a broader portfolio, Clariant concentrates on areas like catalysts and sustainable chemicals.
What are the key factors to evaluate for CLZNY?
Evaluate CLZNY on fundamentals, analyst consensus, and risk factors. Clariant AG presents a mixed investment thesis. The dividend yield of 5.74% may attract income-seeking investors. Not financial advice.
How frequently does CLZNY data refresh on this page?
CLZNY's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CLZNY's recent stock price performance?
Clariant AG (CLZNY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CLZNY overvalued or undervalued right now?
Clariant AG (CLZNY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of CLZNY?
Yes, most major brokerages offer fractional shares of Clariant AG (CLZNY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CLZNY's earnings and financial reports?
Clariant AG (CLZNY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for CLZNY earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC market data may have limited reliability.